CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases 2021

Biocon  /  News – Posts  /  Press Releases  /  Press Releases 2021

Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US
  • Mon, 04-Oct-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance
  • Thu, 16-Sep-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
  • Thu, 29-Jul-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19
  • Mon, 26-Jul-2021
  • Posted by: BIOCON
No Comments

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr;

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr;
  • Fri, 23-Jul-2021
  • Posted by: BIOCON
No Comments

Biocon Q4FY21 Revenue at Rs 2,044 Cr, Up 26%; EBITDA at Rs 641 Cr; Up 68%
  • Thu, 29-Apr-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics’ New Monoclonal Antibodies Manufacturing Facility Wins ISPE’s 2021 Facility of the Year Honorable Mention Award
  • Wed, 28-Apr-2021
  • Posted by: BIOCON
No Comments

Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil

Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab
  • Mon, 29-Mar-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets

Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets
  • Tue, 02-Mar-2021
  • Posted by: BIOCON
No Comments

Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer

Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer
  • Mon, 01-Mar-2021
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>